MH—Ni电池封口化成及其性能

在硼氢化钾碱性溶液中对金属氢化物（ＭＨ）电极的表面进行化学还原处理，提高了ＭＨ电极的放电容量、活化性能和电催化活性．用其为负极组装的ＡＡ型ＭＨ－Ｎｉ电池进行了封口化成，电池放电容量达到１１５０ｍＡｈ，５Ｃ下电池的放电容量达到０．２Ｃ下容量的８０％以上，电池在１Ｃ１００％ＤＯＤ（放电深度）充放电条件下，循环寿命由原来的１００次左右提高到２００次以上     

Pt羰基簇合物在NaY内的合成机理

利用IR，EXAFS, ~(13)CO同位素交换反应及与NO作用等手段研究了Pt羰基簇合物[Pt_3(CO)_6]~(2-)_n(n＝3,4)在NaY分子筛超笼内的合成机理．在氧化样品Pt~(2+)/NaY上300－373 K的还愿羰基化过程中，首先Pt~(2+)与CO反应生成PtO(CO)物种(波数σ_(CO)＝2110 cm~(-1))，然后聚集成“Pt_3(CO)_6”(σ_(CO)＝2112，1896和1841 cm~(-1))，最后生成深绿色的Pt羰基簇合物Pt_(12)(CO)_(24)]~(2-)/NaY(σ_(CO)＝2080，1824 cm~(-1))．“Pt_3(CO)_6”的羰基在室温下能迅速地与~(13)CO发生交换，而[Pt_3(CO)_6]~(2-)_n(n＝3,4)的羰基与~(13)CO的同位素交换即使在343 K也进行得很慢，室温下，NO能逐步破坏Pt羰基簇合物的层间和层内Pt－Pt键，得到中间物种“Pt_3(CO)_6”和PtO(CO)，同时在气相产生CO_2和N_2O．而由上述两中间物种出发，300－353 K温度下，在CO气氛中的还原羰基化又能可逆地得到原羰基簇合物．     

Heterocyclic inflammation inhibitors

Non steroidal anti-inflammatory drugs are the most widely used medicines for relief of pain. These drugs have some side effects, particularly toxicity in the gastrointestinal tract and kidneys. Various approaches have been used for obtaining safer anti-inflammatory drugs. In this review we have summarized the recent developments in the following areas; (i) mode of action of NSAIDs (ii) Role of COX-1 & COX-2 in inflammation, (iii) Different approaches used to improve gastric tolerance i.e. chemical manipulation, formulation & co-administration, development of non specific (COX-1 & COX-2 inhibitors) and specific (COX-2 inhibitors) inflammation inhibitors, and development of inflammation inhibitors having a mode of action other than COX-1 & COX-2 inhibition. We have also focused on the safety of COX-2 inhibitors and the synthesis of heterocyclic compounds and their role as inflammation inhibitors.     

Synthesis of 7,9-dideoxybaccatin IV analogs from sinenxan A

Sinenxan A, a taxoid isolated from callus tissue cultures of Taxus yunnanensis was converted into 13-oxo-7,9-dideoxy-2-debenzoyl-2-acetyl-baccatin IV and 7,9-dideoxy-2-debenzoyl-4-deacetyl-baccatin IV, a key framework of 1,7,9-trideoxypaclitaxel. Several special steps in this transformation are worthy of note: (1) deoxygenation by treatment with hypophosphorous acid at C-14 position; (2) a highly regioselective O-deacetylation of taxanes at C-5 position; and (3) stereoselective reduction of the 13-carbonyl group by transannular assistance from the C-4-hydroxyl.     

Lysophosphatidic acid induces astrocyte proliferation in hippocampus slices partially through activating extracellular signal-regulated kinases

The goal of the present study is to test the hypothesis that LPA induces proliferation of astrocytes in hippocampus in vivo via phosphorylation of ERK 1/2. We first characterized the expression of GFAP, a special marker fiber protein of astrocytes, in brain slices after direct injection of LPA into hippocampus by immunohistochemistry, and found that LPA induced a remarkable proliferation of astrocytes. Then double-lablled immunofluorescence was used to detect GFAP and phosphorylation ERK 1/2 (p-ERK 1/2), LPA induced an immediate (10 min) and transient (<30 min) phosphorylation of ERK 1/2, and sequence sustained activation of ERK 1/2 was observed, which last for at least 3 weeks after injection of LPA. Reactions are inhibited by U0126, a specific pharmacological mitogen-activated protein kinase (MEK) inhibitor. Laser confocal scanning was used to study spatial relationship of p-ERK and astrocytes. Amazingly, the early (<7 days) phosphorylation of ERK 1/2 is not expressed in astrocytes but in area where neurons and/or in other cell type(s) occupied, expression of p-ERK 1/2 in astrocytes is not detected until 14 days after LPA injection and lasts for at least 3 weeks. Taken together, these data suggest that LPA play an important role in proliferation of astrocytes through phosphorylation of ERK 1/2 in hippocampus. It provides further proof for the functions of LPA in CNS injury, and may contribute to clinical therapy for relative diseases.     

Synthesis, spectroscopic studies and crystal structure of a polyoxoanion cluster incorporating para-bromophenylimido ligand, (Bu4N)2[Mo6O18(NC6H4Br-p)]

An organic-inorganic hybrid compound, (Bu₄N)₂[Mo₆O₁₈(NAr)] (Ar = p-BrC₆H₄) has been synthesized via the DCC dehydrating protocol of the reaction of [α-Mo₈O₂₆]⁴⁻ with 4-bromoaniline hydrochloride in anhydrous acetonitrile, which has been characterized by UV-Vis spectra, ¹H NMR and single crystal X-ray diffraction study. By comparing the UV-Vis spectra, which were used to monitor the reaction, the optimum preparative condition for this compound was also determined. This compound crystallizes in the monoclinic space group P2₁/n, which is featured in a terminal para-bromophenylimido group linked to an Mo atom of a hexamolybdate cluster by a Mo-N triply bond. In addition, there are π-π dimerization of the neighboring cluster anions though the parallel aromatic rings in their crystals.     

Analysis of flavonoids in <Emphasis Type="Italic">Ginkgo biloba</Emphasis> L. and its phytopharmaceuticals by capillary electrophoresis with electrochemical detection

A high-performance capillary electrophoretic (CE) method with electrochemical detection (ED) has been developed for determination of the pharmacologically active flavonoids in Ginkgo biloba L. and phytopharmaceuticals containing its extract. Epicatechin, catechin, rutin, apigenin, luteolin, and quercetin are important flavonoids in this plant. Operated in a wall-jet configuration, a 300 micro m diameter carbon-disk electrode was used as working electrode with good response to the six analytes at +1000 mV (relative to the SCE). Under the optimum conditions, the analytes were separated within 22 min in a borax buffer (pH 9.0). Excellent linearity was obtained over two orders of magnitude and detection limits (S/N=3) ranged from 1.4 x 10(-7) to 5.0 x 10(-7) g mL(-1) for all six analytes. The method was successfully used for assay of Ginkgo biloba L. and its phytopharmaceuticals after a relatively simple extraction procedure; the results obtained were satisfactory.     

4-Aminobicyclo[2.2.2]octanone Derivatives with Antiprotozoal Activities

Summary.  4-Aminobicyclo[2.2.2]octanones which were prepared in one-pot-reactions from benzylidene acetone and dialkylammonium rhodanides were reduced stereoselectively to their corresponding alcohols. The activities of the bicyclic compounds against causative organisms of tropical deseases were examined. The 4-aminobicyclo[2.2.2]octan-2-ols were in general more active against Trypanosoma b. rhodesiense and Plasmodium falciparum than the corresponding keto compounds. Corresponding author. E-mail: robert.weis@uni-graz.at Received November 27, 2002; accepted December 2, 2002 Published online May 2, 2003     

Electrochromic properties of WO<Subscript>3</Subscript> and WO<Subscript>3</Subscript>:P thin films

WO₃ and WO₃:P (5 mol% H₃PO₄) thin films were prepared using the sol-gel route and the electrochromic properties of the films were investigated using in situ spectroelectrochemical methods. The measurements were performed in propylene carbonate solution with 0.1 M LiClO₄ as electrolyte. During the cathodic polarization at –0.8 V a blue coloration is observed with a reversible variation between 14% and 84% of the transmittance at λ=633 nm. The kinetics for the bleaching process is faster for the WO₃:P film than for the undoped WO₃ film. Electronic Publication     

A new isocoumarin from bark of Pellodendron chinense

A new isocoumarin, 3-acetyl-3,4-dihydro-5,6-dimethoxy-1H-2-benzopyran-1-one, was isolated from the cortex of Phellodendron chinense schneid. The structure was determined on the basis of spectroscopic evidences.